Sanofi seeking partners to help introduce bacteriology products in U.S., Japan.
This article was originally published in The Gray Sheet
Executive Summary
SANOFI DIAGNOSTICS SEEKS U.S., JAPANESE PARTNERS TO MARKET BACTERIOLOGY TESTS on fully automated systems as part of the firm's strategy to commercialize its blood culture and susceptibility testing products in the U.S. and Japan. The agreements would be similar to the R&D/marketing agreement forged in conjunction with the proposed sale of the Sanofi Access immunochemistry system to Beckman. Under the follow-up pact, Sanofi's diagnostics division, Sanofi Diagnostics Pasteur, will continue to research new reagents for Access that Beckman will commercialize ("The Gray Sheet" March 31, I&W-1).